Editorial: Advanced glycation end products - a dietary culprit for IBD in the genetically susceptible?

IF 6.6 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Alimentary Pharmacology & Therapeutics Pub Date : 2024-10-17 DOI:10.1111/apt.18240
Fahim Ebrahimi, Anders Forss
{"title":"Editorial: Advanced glycation end products - a dietary culprit for IBD in the genetically susceptible?","authors":"Fahim Ebrahimi,&nbsp;Anders Forss","doi":"10.1111/apt.18240","DOIUrl":null,"url":null,"abstract":"<p>Inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), affects several million people worldwide, mainly in the Western world. However, the incidence is sharply rising in newly industrialized countries.<span><sup>1, 2</sup></span> The adoption of a Western lifestyle, particularly a diet high in sugar, fat and ultra-processed foods, may contribute to this trend.<span><sup>2</sup></span></p><p>As a result, dietary compounds have been investigated for their role in the pathogenesis of IBD.<span><sup>3, 4</sup></span> Among these, advanced glycation end products (AGEs), which are formed during thermal processing of foods, have come to the fore as they increase oxidative stress and inflammation.<span><sup>5</sup></span> Studies have linked AGEs to alterations in the gut microbiome and to pro-inflammatory immune responses.<span><sup>6</sup></span> However, evidence on their role in the risk of developing IBD remains sparse and inconclusive.<span><sup>7, 8</sup></span></p><p>Jiang et al. have reported novel findings from a cohort based on the UK Biobank, including 121,978 individuals without IBD.<span><sup>9</sup></span> Of these, 671 (0.55%) developed IBD during a median follow-up of almost 14 years. Their intake of three AGEs was estimated by dietary questionnaires. Interestingly, the authors found that one of the AGEs was associated with an increased risk of developing IBD, but only CD (adjusted hazard ratio: 1.09; 95% CI: 1.01–1.18). In stratified analyses, the association was strongest in the overweight, the physically inactive and non-smokers. The authors used polygenic risk scores to explore the interaction of diet with the background genetic risk. They found that all three AGEs were associated with a higher risk of CD in individuals at high genetic risk but, again, saw no association for UC.</p><p>Strengths of their study are its large population and the comprehensive genetic profiling. Major limitations include the lack of information on dietary changes over time and measurement bias due to the use of dietary questionnaires to estimate AGEs. Because exact concentrations of AGEs are unknown, these data do not provide sufficient evidence to link these associations to a specific AGE or signalling pathway.</p><p>Nevertheless, this study has elegantly demonstrated the importance of diet in the development of IBD, especially in those with a high background genetic risk. However, several questions remain unanswered. Are AGEs the primary culprit or other compounds present in ultra-processed food and if yes, which specific AGE molecules or pathways are involved? Is there a dose–response relationship between AGEs and the risk of IBD? Can individuals with a high genetic risk of IBD prevent or delay disease onset by maintaining a healthy lifestyle and avoiding high intake of AGEs? In addition, the finding of a stronger association in overweight and physically inactive individuals raises the question of whether the metabolic syndrome with chronic low-grade inflammation might be the actual spark to chronic gut inflammation.</p><p>Moving from correlation to causation is necessary to design preventive dietary strategies for individuals with a high genetic risk of developing IBD. To achieve this, further population-based studies with longitudinal measurements of dietary intake, and studies with granular data on dietary molecules are needed. We are convinced that such efforts will be worthwhile. After all, diet is modifiable, whereas genetics—at least for now—are static.</p><p><b>Fahim Ebrahimi:</b> Conceptualization; writing – original draft; writing – review and editing; methodology. <b>Anders Forss:</b> Project administration; supervision; methodology; writing – original draft; writing – review and editing; conceptualization.</p><p>Declaration of funding interests: This study was funded in part by the Swiss National Science Foundation (grant number P500PM_210866). Research grants from the Bengt Ihre Foundation (grant number SLS-974469), Bengt Ihre Fellowship (2023-1), and the Swedish Society of Medicine also supported this study (grant number SLS-973638).</p><p>This article is linked to Jiang et al paper. To view this article, visit https://doi.org/10.1111/apt.18218</p>","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"60 10","pages":"1449-1450"},"PeriodicalIF":6.6000,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.18240","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apt.18240","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), affects several million people worldwide, mainly in the Western world. However, the incidence is sharply rising in newly industrialized countries.1, 2 The adoption of a Western lifestyle, particularly a diet high in sugar, fat and ultra-processed foods, may contribute to this trend.2

As a result, dietary compounds have been investigated for their role in the pathogenesis of IBD.3, 4 Among these, advanced glycation end products (AGEs), which are formed during thermal processing of foods, have come to the fore as they increase oxidative stress and inflammation.5 Studies have linked AGEs to alterations in the gut microbiome and to pro-inflammatory immune responses.6 However, evidence on their role in the risk of developing IBD remains sparse and inconclusive.7, 8

Jiang et al. have reported novel findings from a cohort based on the UK Biobank, including 121,978 individuals without IBD.9 Of these, 671 (0.55%) developed IBD during a median follow-up of almost 14 years. Their intake of three AGEs was estimated by dietary questionnaires. Interestingly, the authors found that one of the AGEs was associated with an increased risk of developing IBD, but only CD (adjusted hazard ratio: 1.09; 95% CI: 1.01–1.18). In stratified analyses, the association was strongest in the overweight, the physically inactive and non-smokers. The authors used polygenic risk scores to explore the interaction of diet with the background genetic risk. They found that all three AGEs were associated with a higher risk of CD in individuals at high genetic risk but, again, saw no association for UC.

Strengths of their study are its large population and the comprehensive genetic profiling. Major limitations include the lack of information on dietary changes over time and measurement bias due to the use of dietary questionnaires to estimate AGEs. Because exact concentrations of AGEs are unknown, these data do not provide sufficient evidence to link these associations to a specific AGE or signalling pathway.

Nevertheless, this study has elegantly demonstrated the importance of diet in the development of IBD, especially in those with a high background genetic risk. However, several questions remain unanswered. Are AGEs the primary culprit or other compounds present in ultra-processed food and if yes, which specific AGE molecules or pathways are involved? Is there a dose–response relationship between AGEs and the risk of IBD? Can individuals with a high genetic risk of IBD prevent or delay disease onset by maintaining a healthy lifestyle and avoiding high intake of AGEs? In addition, the finding of a stronger association in overweight and physically inactive individuals raises the question of whether the metabolic syndrome with chronic low-grade inflammation might be the actual spark to chronic gut inflammation.

Moving from correlation to causation is necessary to design preventive dietary strategies for individuals with a high genetic risk of developing IBD. To achieve this, further population-based studies with longitudinal measurements of dietary intake, and studies with granular data on dietary molecules are needed. We are convinced that such efforts will be worthwhile. After all, diet is modifiable, whereas genetics—at least for now—are static.

Fahim Ebrahimi: Conceptualization; writing – original draft; writing – review and editing; methodology. Anders Forss: Project administration; supervision; methodology; writing – original draft; writing – review and editing; conceptualization.

Declaration of funding interests: This study was funded in part by the Swiss National Science Foundation (grant number P500PM_210866). Research grants from the Bengt Ihre Foundation (grant number SLS-974469), Bengt Ihre Fellowship (2023-1), and the Swedish Society of Medicine also supported this study (grant number SLS-973638).

This article is linked to Jiang et al paper. To view this article, visit https://doi.org/10.1111/apt.18218

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
社论:高级糖化终产物--遗传易感人群罹患 IBD 的饮食罪魁祸首?
炎症性肠病 (IBD) 包括克罗恩病 (CD) 和溃疡性结肠炎 (UC),全世界有几百万人受其影响,主要是在西方国家。2 因此,人们对膳食化合物在 IBD 发病机制中的作用进行了研究。3, 4 其中,在食品热加工过程中形成的高级糖化终产物(AGEs)因会增加氧化应激和炎症而受到关注。研究表明,AGEs 与肠道微生物组的改变以及促炎症免疫反应有关。6 然而,有关 AGEs 在 IBD 发病风险中的作用的证据仍然稀少,且尚无定论。7, 8Jiang 等人报告了基于英国生物库(UK Biobank)的一个队列的新发现,该队列包括 121,978 名未患 IBD 的个体。他们对三种 AGE 的摄入量是通过饮食调查问卷估算出来的。有趣的是,作者发现其中一种 AGE 与 IBD 患病风险的增加有关,但只与 CD 有关(调整后危险比:1.09;95% CI:1.01-1.18)。在分层分析中,超重者、不运动者和非吸烟者的相关性最强。作者使用多基因风险评分来探讨饮食与背景遗传风险之间的相互作用。他们发现,在遗传风险较高的人群中,所有三种 AGEs 都与较高的 CD 风险有关,但同样与 UC 无关。其主要局限性包括缺乏有关饮食随时间变化的信息,以及由于使用饮食问卷估算 AGEs 而产生的测量偏差。由于 AGEs 的确切浓度尚不清楚,这些数据并不能提供足够的证据将这些关联与特定的 AGE 或信号通路联系起来。尽管如此,这项研究还是很好地证明了饮食在 IBD 发病中的重要性,尤其是在那些具有高背景遗传风险的人群中。然而,仍有几个问题没有得到解答。AGEs是罪魁祸首还是超加工食品中的其他化合物?AGE 与 IBD 风险之间是否存在剂量反应关系?具有 IBD 高遗传风险的人能否通过保持健康的生活方式和避免摄入大量 AGE 预防或推迟疾病的发生?此外,在超重和缺乏运动的人群中发现了更强的关联性,这就提出了一个问题:代谢综合征与慢性低度炎症是否可能是慢性肠道炎症的真正导火索?要实现这一目标,需要进一步开展以人群为基础的研究,对膳食摄入量进行纵向测量,并对膳食分子进行细化研究。我们相信这些努力是值得的。毕竟,饮食是可以改变的,而遗传--至少现在是静态的。法希姆-易卜拉希米:构思;写作--原稿;写作--审阅和编辑;方法论。安德斯-福斯项目管理;监督;方法论;写作-原稿;写作-审阅和编辑;构思:本研究部分由瑞士国家科学基金会资助(资助编号 P500PM_210866)。Bengt Ihre 基金会(资助编号 SLS-974469)、Bengt Ihre 奖学金(2023-1)和瑞典医学会(资助编号 SLS-973638)也为本研究提供了资助。如需查看本文,请访问 https://doi.org/10.1111/apt.18218
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
期刊最新文献
Development and Validation of a PIVKA-II-Based Model for HCC Risk Stratification in Patients With HCV-Related Cirrhosis Successfully Treated With DAA Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease? Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Authors' Reply. Review Article: Green Management of IBD-New Paradigms for an Eco-Friendly Approach. Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's Disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1